NCT00473161

Brief Summary

A newly-developed device for biofeedback of surface EMG will be used to either increase or decrease activity in the muscles of children with poor reaching due to cerebral palsy.

Trial Health

80
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2007

Completed
10 days until next milestone

First Submitted

Initial submission to the registry

May 11, 2007

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 14, 2007

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2009

Completed
Last Updated

May 23, 2014

Status Verified

May 1, 2014

Enrollment Period

1.7 years

First QC Date

May 11, 2007

Last Update Submit

May 21, 2014

Conditions

Cerebral PalsyWeaknessHypertonia

Keywords

movement disorderschildhood

Interventions

surface EMG biofeedbackDEVICE

Eligibility Criteria

Age1 Month - 21 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Children with movement disorders, cerebral palsy.

You may qualify if:

  • weakness, hypertonia, or hyperkinetic disorder affecting one or both arms
  • reduced speed or quality of reaching

You may not qualify if:

  • any condition that would increase the risk of participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Stanford University

Stanford, California, 94305, United States

Location

MeSH Terms

Conditions

Cerebral PalsyAstheniaMuscle HypertoniaMovement Disorders

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsNeuromuscular ManifestationsNeurologic Manifestations

Study Officials

  • Terence D Sanger, MD PhD

    Stanford University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

May 11, 2007

First Posted

May 14, 2007

Study Start

May 1, 2007

Primary Completion

January 1, 2009

Last Updated

May 23, 2014

Record last verified: 2014-05

Locations

US(1)